Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Operating Margin (2018 - 2025)

Dna X (SONM) has disclosed Operating Margin for 8 consecutive years, with 24.55% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Margin fell 873.0% year-over-year to 24.55%, compared with a TTM value of 48.18% through Sep 2025, down 2564.0%, and an annual FY2024 reading of 57.7%, down 5825.0% over the prior year.
  • Operating Margin was 24.55% for Q3 2025 at Dna X, up from 60.16% in the prior quarter.
  • Across five years, Operating Margin topped out at 3.86% in Q1 2025 and bottomed at 97.62% in Q4 2024.
  • Average Operating Margin over 5 years is 34.1%, with a median of 24.55% recorded in 2025.
  • The sharpest move saw Operating Margin soared 6931bps in 2022, then plummeted -8828bps in 2024.
  • Year by year, Operating Margin stood at 73.71% in 2021, then skyrocketed by 94bps to 4.39% in 2022, then crashed by -113bps to 9.34% in 2023, then crashed by -945bps to 97.62% in 2024, then surged by 75bps to 24.55% in 2025.
  • Business Quant data shows Operating Margin for SONM at 24.55% in Q3 2025, 60.16% in Q2 2025, and 3.86% in Q1 2025.